Daan Bosshardt

Mr. Daan Bosshardt

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2024 in Heart
Verified
Journal Article
Open access
PDF file
MAMitzi van Andel
Mitzi van Andel
DBDaan Bosshardt
Daan Bosshardt
ESEric M Schrauben
Eric M Schrauben
RMRenske Merton
Renske Merton
RKRoland van Kimmenade
Roland van Kimmenade
Vivian de WaardVivian de Waard
Vivian de Waard
Background Resveratrol, a dietary supplement that intervenes in cellular metabolism, has been shown to reduce aortic growth rate in a mouse model of Marfan syndrome (MFS), a condition associated in humans with life-threatening aortic complications, often preceded by aortic dilatation. The primary objective of this study was to investigate the effects of resveratrol on aortic growth rate in patients with MFS . Methods In this investigator-initiated, single-arm open-label multicentre trial, we analysed resveratrol treatment in adults aged 18–50 years with MFS. The primary endpoint was the change in estimated annual aortic growth at five predefined levels in the thoracic aorta after 1 year of resveratrol treatment, evaluated using a linear mixed model. Aortic diameters were measured by cardiac MRI at three time points to analyse the annual aortic expansion rate before and after initiation of treatment. Additionally, annual aortic growth was compared with growth in a previously conducted losartan randomised clinical trial. Results 898 patients were screened of which 19% (168/898) patients met the inclusion criteria. 36% (61/168) patients signed informed consent and 93% (57/61) aged 37±9 years, of which 28 males (49%) were included in the final analysis of the study. 46% (26/57) had undergone aortic root replacement prior to the study. Aortic root diameters remained stable after 1.2±0.3 years of resveratrol administration. A trend towards a decrease in estimated growth rate (mm/year) was observed in the aortic root (from 0.39±0.06 to −0.13±0.23, p=0.072), ascending aorta (from 0.40±0.05 to −0.01±0.18, p=0.072) and distal descending aorta (from 0.32±0.04 to 0.01±0.14, p=0.072). Conclusion Resveratrol treatment for 1 year may stabilise the aortic growth rate in adult patients with MFS. However, a subsequent randomised clinical trial with a longer follow-up duration and a larger study cohort is needed to establish an actual long-term beneficial effect of this dietary supplement in patients with MFS. Trial registration number NL66127.018.18.

19 April 2023 in International Journal of Cardiology Congenital Heart Disease
Verified
Journal Article
Open access
DBDaan Bosshardt
Daan Bosshardt
MVMichiel Voskuil
Michiel Voskuil
GKGregor J. Krings
Gregor J. Krings
MMMirella M.C. Molenschot
Mirella M.C. Molenschot
MSMaarten J. Suttorp
Maarten J. Suttorp
MPMartijn C. Post
Martijn C. Post
In order to prevent right ventricular (RV) dysfunction, closure of secundum type atrial septal defects (ASD) is often indicated and percutaneous closure is the preferred treatment modality to do so. The magnitude and time course of RV remodeling is still incompletely understood. This retrospective cohort study included consecutive patients who underwent percutaneous secundum ASD closure in two tertiary referral centers in The Netherlands. Main study parameters were RV and right atrial dimensions measured with transthoracic echocardiography before and after percutaneous ASD closure. Secondary outcome was change in New York Heart Association (NYHA) functional class at follow-up. From the 454 patients who underwent secundum ASD closure, 88 patients (median age 46 [range 17–84]) were included. The majority of RV and right atrial dimensional improvement occurred within 24 h. After a median follow-up of 569 days (IQR: 280–772) a further decrease in dimensions was observed. Comparing baseline and latest follow-up, end-diastolic RV basal diameter decreased from 4.5 SEM 0.1 to 3.9 SEM 0.1 cm (p < 0.001) and end-systolic right atrial area from 22.9 SEM 1.0 to 17.9 SEM 0.7 cm2 (p < 0.001). No significant changes in RV function were observed. NYHA functional class improved from 1.5 at baseline (IQR: 1.0–2.0) to 1.0 (IQR: 1.0–1.5) at latest follow-up (p < 0.001). Remodeling of the RV heart dimensions commences within 24 h after percutaneous secundum ASD closure for the majority of patients, followed by a further gradual recovery. A concurrent improvement of NYHA functional class was observed during follow-up.

30 October 2025 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
DBDaan Bosshardt
Daan Bosshardt
RMRenske Merton
Renske Merton
BSBibi A. Schreurs
Bibi A. Schreurs
RKRoland R.J. van Kimmenade
Roland R.J. van Kimmenade
ANAart J. Nederveen
Aart J. Nederveen
POPim van Ooij
Pim van Ooij
Acute aortic syndromes in Marfan syndrome (MFS) often occur before reaching the surgical diameter threshold, highlighting the need for new imaging biomarkers. Aim was to compare CMR-derived aortic three-dimensional (3D) distensibility and displacement in MFS patients with or without a history of aortic root surgery (RR or native) and healthy volunteers. The participants underwent 3T CMR of the thoracic aorta using an accelerated non-contrast-enhanced, free breathing, 3D cine balanced steady state free precession sequence, with spatiotemporal resolution: (1.0mm)3/~33ms. A deep learning-based algorithm was used to obtain aorta segmentations. Non-rigid registration of these segmentations was subsequently used to calculate 3D distensibility and its separate components: 2-dimensional distensibility, longitudinal strain, and displacement in the ascending (AAo) and descending aorta (DAo). Forty-seven volunteers, 51 native, and 33 RR MFS patients were included. AAo and DAo distensibility (10-3*mmHg-1) were different for healthy volunteers vs native vs RR patients (AAo: 5.1±1.4 vs 3.6±1.4 vs. 1.4 ± 0.7, p<0.001, DAo: 3.2±1.1 vs. 2.5±0.9 vs 2.4±1.0, p=0.001). Sinotubular junction displacement (mm) was significantly higher for healthy volunteers vs native MFS vs RR MFS patients (10.3±1.3 vs 8.7±2.1 vs 5.7±1.6, p<0.001). In native patients, age (β=-0.06 (95% CI:-0.10 - -0.01), p=0.014) and root diameter (β=-0.1 (95% CI: -0.19 - -0.02), p=0.018) were negatively associated with AAo 3D distensibility, independent of male sex, body surface area, and aortic tortuosity index. Aortic 3D distensibility and displacement, derived from 4-dimensional CMR, were significantly diminished in MFS compared to volunteers and should be investigated longitudinally to assess their potential value in predicting aortic events and guiding therapy.

30 June 2025 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
DBDaan Bosshardt
Daan Bosshardt
MAMitzi M. van Andel
Mitzi M. van Andel
ESE. M. Schrauben
E. M. Schrauben
RKRoland R. J. van Kimmenade
Roland R. J. van Kimmenade
ASArthur J. Scholte
Arthur J. Scholte
POPim van Ooij
Pim van Ooij
Background: New treatment strategies are required to reduce aortic events in Marfan syndrome (MFS). Resveratrol is a dietary supplement that intervenes in aortic wall cellular metabolism and may benefit MFS patients.Purpose: To evaluate whether treatment with Resveratrol affects aorta hemodynamics derived from 4D flow MRI in MFS.Study Type: Prospective single‐arm open‐label multicenter trial.Population: 46 MFS patients (mean age 36 ± 9 years, 23 female), 20 with and 26 without a history of aortic root surgery (RR and native MFS), and 25 age‐ and sex‐matched healthy controls.Field Strength/Sequence: 3T, temporally resolved 3D phase contrast (4D flow MRI) and 3D mDixon sequences.Assessment: MFS patients underwent 4D flow MRI before (baseline) and after 1 year of 500 mg daily Resveratrol treatment (follow‐up). Velocity magnitude and wall shear stress (WSS) in six regions in the thoracic aorta were evaluated. Incidence maps showing abnormal hemodynamics compared to healthy controls were generated. Pulse wave velocity (PWV) was assessed in 45 subjects. The relationships between MRI parameters and annual aortic growth from the 3D mDixon scans and age were investigated.Statistical Tests: Student's paired and unpaired t‐tests, Fisher's exact tests, McNemar's exact test, and Pearson correlation coefficients (r). Statistical significance was defined as p < 0.05.Results: No significant changes in any of the hemodynamic parameters were observed: inner descending aorta WSS (Pa), native: from 1.08 ± 0.21 to 1.08 ± 0.17, p = 0.818, RR: from 1.02 ± 0.29 to 0.98 ± 0.21, p = 0.270; velocity (m/s), native: from 0.64 ± 0.10 to 0.65 ± 0.10, p = 0.359, RR: 0.68 ± 0.15, to 0.67 ± 0.12, p = 0.629; abnormally directed WSS incidence: native: from 17 (65%) to 14 (54%), p = 0.453, RR: 13 (65%) to 13 (65%), p = 1.000; PWV (m/s) native: from 7.7 ± 1.9 to 7.9 ± 1.8, p = 0.582, RR: 9.2 ± 1.6 to 8.2 ± 3.2, p = 0.184. PWV correlated with age in RR MFS patients (r = 0.59, n = 19).Data Conclusion: No significant changes in aortic hemodynamics derived from 4D flow MRI were observed after 1 year of Resveratrol treatment.Evidence Level: 1.Technical Efficacy: Stage 4.

21 September 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
RMRenske Merton
Renske Merton
DBDaan Bosshardt
Daan Bosshardt
GSGustav Strijkers
Gustav Strijkers
ANAart J. Nederveen
Aart J. Nederveen
ESEric M. Schrauben
Eric M. Schrauben
POPim van Ooij
Pim van Ooij
Pulse wave velocity (PWV) is a key marker of aortic stiffness and cardiovascular risk, yet current methods typically offer only global or regional estimates and lack the possibility to measure local variations along the thoracic aorta. This study aimed to develop and evaluate a pipeline for assessing local aortic PWV using the flow–area (QA) method (PWVQA) by combining high-resolution 4D MRI techniques. A 3D cine balanced steady-state free precession (bSSFP) sequence was used to capture dynamic changes in aortic geometry, while 4D flow MRI measured time-resolved blood flow. The QA method was applied during the reflection-free early systolic phase. Scan–rescan reproducibility was assessed in six healthy volunteers, and feasibility was additionally explored in Marfan syndrome patients. The mean ± SD values of the Pearson correlation coefficients for per-slice maximum area, velocity, flow, and PWVQA were 0.99 ± 0.00, 0.82 ± 0.11, 0.96 ± 0.01, and 0.20 ± 0.35, respectively. The median (Q1–Q3) average PWVQA was 6.6 (5.4–9.4) m/s for scan 1 and 9.1 (6.7–11.3) m/s for scan 2 (p = 0.16) in healthy volunteers and 7.1 (6.9–8.0) m/s in Marfan patients. Combining 4D bSSFP and 4D flow MRI is technically feasible, but the derived PWVQA maps show high variability, particularly in the aortic root and descending aorta, requiring further optimization.

20 April 2026 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
DBDaan Bosshardt
Daan Bosshardt
RMRenske Merton
Renske Merton
ANAart J. Nederveen
Aart J. Nederveen
RKRoland R.J. van Kimmenade
Roland R.J. van Kimmenade
MCMoniek G.P.J. Cox
Moniek G.P.J. Cox
POPim van Ooij
Pim van Ooij
Marfan syndrome (MFS) patients with a history of aortic root surgery (ARS) are at increased risk of type B aortic dissection, possibly because the noncompliant graft fails to absorb systolic forces, leading to undampened flow in the proximal descending aorta (pDAo). In this study we investigated the magnitude and location of abnormal aortic displacement and wall shear stress (WSS) using cardiac magnetic resonance imaging (CMR). We examined 82 MFS patients (32 with ARS, 34±8 years, 36 women) and 45 age- and sex-matched controls, all undergoing 4D high resolution CINE and flow CMR. Peak displacement and WSS were calculated using automated aortic segmentations. Heatmaps were created to identify and quantify regions with abnormal displacement and WSS. The surface areas of abnormal displacement and WSS were quantified in four aortic regions. The Wilcoxon signed-rank test was used for comparison of abnormal CMR parameter quantification, and Pearson correlation was used to assess correlations between displacement and WSS. WSS was higher in the proximal (p<0.001) and distal ascending aorta (p=0.031) of ARS MFS patients compared to native MFS patients. ARS MFS patients had significantly larger surface areas of decreased displacement (p<0.001; present in 97% of ARS MFS patients) and increased WSS (p<0.001; present in 100% of patients) in the proximal ascending aorta. There was a trend toward a larger surface area of increased displacement in the pDAo of ARS MFS patients (p=0.062; present in 72% of patients), mainly located in the outer pDAo. pDAo displacement was positively correlated with pDAo WSS (Pearson r=0.46 [95%CI: 0.13, 0.70], p=0.008). Aortic displacement and flow characteristics are abnormal in MFS patients, both with and without a history of aortic root surgery. ARS MFS patients exhibit distinct features in both the AAo and DAo, particularly in the proximal DAo, which is the region susceptible to type B aortic dissections.